280 related articles for article (PubMed ID: 24464704)
1. Application of a subtractive genomics approach for in silico identification and characterization of novel drug targets in Mycobacterium tuberculosis F11.
Hosen MI; Tanmoy AM; Mahbuba DA; Salma U; Nazim M; Islam MT; Akhteruzzaman S
Interdiscip Sci; 2014 Mar; 6(1):48-56. PubMed ID: 24464704
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of potential druggable targets among hypothetical proteins of extensively drug resistant Mycobacterium tuberculosis (XDR KZN 605) through subtractive genomics approach.
Uddin R; Siddiqui QN; Azam SS; Saima B; Wadood A
Eur J Pharm Sci; 2018 Mar; 114():13-23. PubMed ID: 29174549
[TBL] [Abstract][Full Text] [Related]
3. Identification of putative drug targets in Vancomycin-resistant Staphylococcus aureus (VRSA) using computer aided protein data analysis.
Hasan MA; Khan MA; Sharmin T; Hasan Mazumder MH; Chowdhury AS
Gene; 2016 Jan; 575(1):132-43. PubMed ID: 26319513
[TBL] [Abstract][Full Text] [Related]
4. Proteome-wide subtractive approach to prioritize a hypothetical protein of XDR-Mycobacterium tuberculosis as potential drug target.
Uddin R; Siddiqui QN; Sufian M; Azam SS; Wadood A
Genes Genomics; 2019 Nov; 41(11):1281-1292. PubMed ID: 31388979
[TBL] [Abstract][Full Text] [Related]
5. Potential drug targets in Mycobacterium tuberculosis through metabolic pathway analysis.
Anishetty S; Pulimi M; Pennathur G
Comput Biol Chem; 2005 Oct; 29(5):368-78. PubMed ID: 16213791
[TBL] [Abstract][Full Text] [Related]
6. Genome Subtraction and Comparison for the Identification of Novel Drug Targets against
Uddin R; Siraj B; Rashid M; Khan A; Ahsan Halim S; Al-Harrasi A
Pathogens; 2020 May; 9(5):. PubMed ID: 32408506
[No Abstract] [Full Text] [Related]
7. In Silico Drug Target Discovery Through Proteome Mining from M. tuberculosis: An Insight into Antivirulent Therapy.
Bhattacharya S; Ghosh P; Banerjee D; Banerjee A; Ray S
Comb Chem High Throughput Screen; 2020; 23(3):253-268. PubMed ID: 32072892
[TBL] [Abstract][Full Text] [Related]
8. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
9. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
10. targetTB: a target identification pipeline for Mycobacterium tuberculosis through an interactome, reactome and genome-scale structural analysis.
Raman K; Yeturu K; Chandra N
BMC Syst Biol; 2008 Dec; 2():109. PubMed ID: 19099550
[TBL] [Abstract][Full Text] [Related]
11. Identification of glucosyl-3-phosphoglycerate phosphatase as a novel drug target against resistant strain of Mycobacterium tuberculosis (XDR1219) by using comparative metabolic pathway approach.
Uddin R; Zahra NU; Azam SS
Comput Biol Chem; 2019 Apr; 79():91-102. PubMed ID: 30743161
[TBL] [Abstract][Full Text] [Related]
12. A multi-level multi-scale approach to study essential genes in Mycobacterium tuberculosis.
Ghosh S; Baloni P; Mukherjee S; Anand P; Chandra N
BMC Syst Biol; 2013 Dec; 7():132. PubMed ID: 24308365
[TBL] [Abstract][Full Text] [Related]
13. Identification of putative non-host essential genes and novel drug targets against Acinetobacter baumannii by in silico comparative genome analysis.
Uddin R; Masood F; Azam SS; Wadood A
Microb Pathog; 2019 Mar; 128():28-35. PubMed ID: 30550846
[TBL] [Abstract][Full Text] [Related]
14. Application of the Subtractive Genomics and Molecular Docking Analysis for the Identification of Novel Putative Drug Targets against
Hossain T; Kamruzzaman M; Choudhury TZ; Mahmood HN; Nabi AHMN; Hosen MI
Biomed Res Int; 2017; 2017():3783714. PubMed ID: 28904956
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of potential drug targets by subtractive genome analyses of methicillin resistant Staphylococcus aureus.
Uddin R; Saeed K
Comput Biol Chem; 2014 Feb; 48():55-63. PubMed ID: 24361957
[TBL] [Abstract][Full Text] [Related]
16. Functional, structural and epitopic prediction of hypothetical proteins of Mycobacterium tuberculosis H37Rv: An in silico approach for prioritizing the targets.
Gazi MA; Kibria MG; Mahfuz M; Islam MR; Ghosh P; Afsar MN; Khan MA; Ahmed T
Gene; 2016 Oct; 591(2):442-55. PubMed ID: 27374154
[TBL] [Abstract][Full Text] [Related]
17. T-iDT : tool for identification of drug target in bacteria and validation by Mycobacterium tuberculosis.
Singh NK; Selvam SM; Chakravarthy P
In Silico Biol; 2006; 6(6):485-93. PubMed ID: 17518759
[TBL] [Abstract][Full Text] [Related]
18. Exploring optimal drug targets through subtractive proteomics analysis and pangenomic insights for tailored drug design in tuberculosis.
Khan MF; Ali A; Rehman HM; Noor Khan S; Hammad HM; Waseem M; Wu Y; Clark TG; Jabbar A
Sci Rep; 2024 May; 14(1):10904. PubMed ID: 38740859
[TBL] [Abstract][Full Text] [Related]
19. Comparative proteome-wide study for in-silico identification and characterization of indispensable hypothetical proteins of food borne-pathogen Campylobacter jejuni (CJJ) by subtractive genomics approach.
Uddin R; Arif A; Zahra NU; Sufian M
Pak J Pharm Sci; 2021 Jul; 34(4):1359-1367. PubMed ID: 34799308
[TBL] [Abstract][Full Text] [Related]
20. Characterizing the pocketome of Mycobacterium tuberculosis and application in rationalizing polypharmacological target selection.
Anand P; Chandra N
Sci Rep; 2014 Sep; 4():6356. PubMed ID: 25220818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]